BIB Holdings
ProShares Ultra Nasdaq Biotechnology
1W: -4.1%
1M: -9.9%
3M: +3.2%
YTD: +37.8%
1Y: +75.2%
3Y: +131.1%
5Y: +9.4%
$109.80
-0.67 (-0.61%)
Weekly Expected Move ±5.7%
$97
$103
$110
$116
$122
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Dividends
Weather
ETF-Level Metrics
AUM$89M
Holdings246
Top 10 Wt41.5%
Beta1.20
% Profitable23%
Coverage54%
Portfolio Valuation
P/E40.6
P/B7.9
P/S6.7
EV/EBITDA26.5
P/FCF22.0
PEG3.15
Profitability & Returns
Gross Margin76.1%
Net Margin9.8%
ROE11.6%
ROA4.4%
ROIC10.2%
Div Yield0.54%
Leverage & Liquidity
Debt/Equity1.05
Debt/Assets0.39
Net Debt/EBITDA1.8x
Interest Cov4.5x
Current Ratio1.83
Quick Ratio1.53
Growth (YoY)
Revenue+29.0%
Net Income+6.8%
EPS+11.0%
FCF+21.8%
EBITDA+10.8%
Rev CAGR 3Y+37.2%
Quality Scores
Piotroski F5.0
Altman Z12.14
IS Quality60.2
IS Overall54.8
IS Value38.8
Median P/E-5.0
Sector Breakdown
3 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 246 | 54.5% | -5.7 |
| Other | 10 | 27.9% | — |
| Financial Services | 1 | 17.6% | — |
Smart Money Overlap
1 holdings with signals| Symbol | Company | Weight % | Signals | Badge | Insider Buys | Congress | Since Signal |
|---|---|---|---|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals, Inc. | 0.13% | 3 | Bullish | 1 | 0 | +99.5% |
Showing 50 of 257 holdings
· Page 1 of 6
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Net Other Assets (Liabilities) Private | — | 27.79% | $26.9M | 26,895,259 | — | — | — |
| 2 | PROSHARES GENIUS MNY MKT ETF | IQMM | 17.57% | $17.0M | 170,000 | — | $17M | Financial Services |
| 3 | GILEAD SCIENCES INC | GILD | 4.46% | $4.3M | 28,945 | -55.7 | $179.5B | Healthcare |
| 4 | AMGEN INC | AMGN | 4.29% | $4.2M | 9,854 | 24.8 | $217.5B | Healthcare |
| 5 | VERTEX PHARMACEUTICALS INC | VRTX | 4.20% | $4.1M | 7,779 | 29.1 | $128.1B | Healthcare |
| 6 | MODERNA INC | MRNA | 2.75% | $2.7M | 13,843 | -23.8 | $75.4B | Healthcare |
| 7 | REGENERON PHARMACEUTICALS | REGN | 2.75% | $2.7M | 3,507 | 17.6 | $75.7B | Healthcare |
| 8 | REVOLUTION MEDICINES INC | RVMD | 1.58% | $1.5M | 7,432 | -23.3 | $43.9B | Healthcare |
| 9 | ILLUMINA INC | ILMN | 1.48% | $1.4M | 5,236 | 50.5 | $41.3B | Healthcare |
| 10 | BIOGEN INC | BIIB | 1.20% | $1.2M | 5,123 | 38.7 | $32.5B | Healthcare |
| 11 | ALNYLAM PHARMACEUTICALS INC | ALNY | 1.18% | $1.1M | 4,640 | 36.0 | $29.4B | Healthcare |
| 12 | ROIVANT SCIENCES LTD | ROIV | 0.95% | $915,896 | 25,045 | -94.0 | $25.8B | Healthcare |
| 13 | ARGENX SE - ADR | ARGX | 0.94% | $907,129 | 946 | 33.3 | $57.2B | Healthcare |
| 14 | ROYALTY PHARMA PLC- CL A | RPRX | 0.93% | $901,020 | 15,439 | 23.7 | $25.3B | Healthcare |
| 15 | INSMED INC | INSM | 0.89% | $864,268 | 7,572 | -27.0 | $24.1B | Healthcare |
| 16 | INCYTE CORP | INCY | 0.88% | $852,848 | 7,028 | 14.2 | $23.4B | Healthcare |
| 17 | GUARDANT HEALTH INC | GH | 0.86% | $829,909 | 4,653 | -50.9 | $23.9B | Healthcare |
| 18 | UNITED THERAPEUTICS CORP | UTHR | 0.83% | $805,790 | 1,487 | 17.9 | $23.0B | Healthcare |
| 19 | VIATRIS INC | VTRS | 0.73% | $705,681 | 39,824 | -48.9 | $20.5B | Healthcare |
| 20 | MEDPACE HOLDINGS INC | MEDP | 0.62% | $603,582 | 967 | 34.5 | $16.7B | Healthcare |
| 21 | JAZZ PHARMACEUTICALS PLC | JAZZ | 0.54% | $521,152 | 2,251 | 15.5 | $14.8B | Healthcare |
| 22 | EXELIXIS INC | EXEL | 0.52% | $501,800 | 8,591 | 17.7 | $14.7B | Healthcare |
| 23 | NEUROCRINE BIOSCIENCES INC | NBIX | 0.52% | $499,986 | 3,525 | 20.3 | $14.4B | Healthcare |
| 24 | TEMPUS AI INC-CL A | TEM | 0.51% | $498,034 | 6,081 | -53.6 | $13.4B | Healthcare |
| 25 | ASCENDIS PHARMA A/S | ASND | 0.50% | $486,189 | 2,134 | 16.7 | $14.2B | Healthcare |
| 26 | SUMMIT THERAPEUTICS INC | SMMT | 0.48% | $467,731 | 27,660 | -15.0 | $13.4B | Healthcare |
| 27 | BRIDGEBIO PHARMA INC | BBIO | 0.47% | $457,507 | 6,953 | -18.8 | $13.2B | Healthcare |
| 28 | BEONE MEDICINES LTD-ADR | ONC | 0.47% | $454,863 | 1,243 | 26.3 | $38.3B | Healthcare |
| 29 | TWIST BIOSCIENCE CORP | TWST | 0.46% | $444,452 | 2,300 | -85.0 | $11.7B | Healthcare |
| 30 | HALOZYME THERAPEUTICS INC | HALO | 0.45% | $434,424 | 3,935 | 31.2 | $13.0B | Healthcare |
| 31 | MADRIGAL PHARMACEUTICALS INC | MDGL | 0.42% | $403,672 | 801 | -38.7 | $11.5B | Healthcare |
| 32 | BIOMARIN PHARMACEUTICAL INC | BMRN | 0.42% | $402,720 | 6,712 | 150.5 | $11.1B | Healthcare |
| 33 | BIONTECH SE-ADR | BNTX | 0.41% | $394,576 | 4,014 | -12.7 | $24.3B | Healthcare |
| 34 | 10X GENOMICS INC-CLASS A | TXG | 0.39% | $376,620 | 4,168 | -158.5 | $11.9B | Healthcare |
| 35 | IMMUNITYBIO INC | IBRX | 0.36% | $346,892 | 36,747 | -10.6 | $10.8B | Healthcare |
| 36 | KRYSTAL BIOTECH INC | KRYS | 0.35% | $341,539 | 1,027 | 39.0 | $9.5B | Healthcare |
| 37 | AXSOME THERAPEUTICS INC | AXSM | 0.35% | $334,852 | 1,816 | -47.8 | $9.2B | Healthcare |
| 38 | KYMERA THERAPEUTICS INC | KYMR | 0.33% | $322,402 | 2,884 | -33.0 | $8.8B | Healthcare |
| 39 | ARROWHEAD PHARMACEUTICALS IN | ARWR | 0.33% | $320,509 | 4,897 | -28.7 | $9.0B | Healthcare |
| 40 | CYTOKINETICS INC | CYTK | 0.33% | $317,686 | 4,820 | -9.1 | $8.2B | Healthcare |
| 41 | PROTAGONIST THERAPEUTICS INC | PTGX | 0.33% | $316,016 | 2,243 | 115.0 | $9.0B | Healthcare |
| 42 | SANOFI-ADR | SNY | 0.32% | $308,194 | 7,475 | 21.7 | $95.9B | Healthcare |
| 43 | CARIS LIFE SCIENCES INC | CAI | 0.31% | $300,143 | 9,799 | 76.1 | $8.0B | Healthcare |
| 44 | VAXCYTE INC | PCVX | 0.30% | $293,547 | 5,159 | -7.4 | $8.2B | Healthcare |
| 45 | PRAXIS PRECISION MEDICINES I | PRAX | 0.29% | $281,911 | 968 | -22.8 | $8.2B | Healthcare |
| 46 | SPYRE THERAPEUTICS INC | SYRE | 0.28% | $272,165 | 3,057 | -47.8 | $8.1B | Healthcare |
| 47 | IONIS PHARMACEUTICALS INC | IONS | 0.27% | $257,273 | 5,762 | -12.6 | $7.2B | Healthcare |
| 48 | AMNEAL PHARMACEUTICALS INC | AMRX | 0.25% | $243,211 | 12,076 | 40.8 | $6.5B | Healthcare |
| 49 | IMMUNOVANT INC | IMVT | 0.25% | $241,899 | 7,161 | -11.9 | $6.9B | Healthcare |
| 50 | ALKERMES PLC | ALKS | 0.24% | $235,705 | 5,817 | 103.6 | $7.0B | Healthcare |